Fortress Biotech Inc (FBIO)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Fortress Biotech Inc Stock (FBIO) Company Profile

Fortress Biotech Inc

781-652-4500

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Prossima data di guadagno

Ultimi documenti SEC

FBIO's Discussions on Twitter

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-04	Iniziato	Ladenburg Thalmann	Buy
2020-10-02	Iniziato	The Benchmark Company	Buy
2019-12-18	Iniziato	B. Riley FBR	Buy
2018-02-28	Iniziato	B. Riley FBR, Inc.	Buy
2017-07-11	Iniziato	Rodman & Renshaw	Buy
2017-03-22	Iniziato	JMP Securities	Mkt Outperform
2016-10-03	Iniziato	ROTH Capital	Buy

Mostra tutto

Fortress Biotech Inc Borsa (FBIO) Ultime notizie

Fortress Biotech Inc Azioni (FBIO) Dati Finanziari

Fortress Biotech Inc Azioni (FBIO) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Jin David	Chief Financial Officer	Jul 10 '24	Buy	7.50	500	3,750	500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jul 09 '24	Buy	7.39	5,000	36,971	122,500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jul 08 '24	Buy	7.35	5,000	36,764	117,500
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jun 28 '24	Buy	1.64	20,000	32,724	2,893,905
ROSENWALD LINDSAY A MD	President, CEO & Chairman	May 16 '24	Buy	1.76	10,000	17,589	2,873,905
Klein Dov	Director	May 20 '24	Sale	1.89	10,000	18,900	53,400
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Jan 05 '24	Buy	2.38	50,000	118,770	2,863,905
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Nov 14 '23	Buy	1.70	1,567,515	2,664,776	2,597,440
WEISS MICHAEL S	See Remarks	Nov 14 '23	Buy	1.70	147,058	249,999	1,130,520
ROSENWALD LINDSAY A MD	President, CEO & Chairman	Sep 26 '23	Buy	0.28	100,000	28,330	15,449,091

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc Stock (FBIO) Company Profile

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Fortress Biotech Inc Borsa (FBIO) Ultime notizie

Checkpoint Therapeutics Announces Cosibelimab Longer-Term - GlobeNewswire

Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - StockTitan

Fortress Biotech Pref A stock hits 52-week low at $6.06 - Investing.com Canada

Fortress Biotech Inc [FBIO] President, CEO & Chairman makes an insider purchase of 5,000 shares worth 37418.0. - Knox Daily

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Does Fortress Biotech Inc (FBIO) offer a good opportunity for investors? - SETE News

Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance

Fortress Biotech, India Fund, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

Long Term Trading Analysis for (FBIOP) - Stock Traders Daily

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - MSN

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 20, 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) 14-Day RSI : 43.84 (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Volatility : 47.06% (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB0.PFD) EBITDA per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) GF Value Rank : 2 (As of Aug. 18, 2024) - GuruFocus.com

Fortress Biotech, B. Riley Financial, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

FBIOP.PFD (Fortress Biotech) EV-to-Revenue : 0.00 (As of Aug. 17, 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com India

Fortress Biotech (STU:CNB1) Inventory-to-Revenue : 0.68 (As of Jun. 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) PE Ratio (TTM) : At Loss (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Canada

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Australia

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com UK

Fortress Biotech, Inc. to Post Q3 2024 Earnings of ($0.27) Per Share, Roth Capital Forecasts (NASDAQ:FBIO) - Defense World

Fortress Biotech (NASDAQ:FBIO) Upgraded by StockNews.com to Hold - Defense World

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com India

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Australia

Understanding the Risks of Investing in Fortress Biotech Inc (FBIO) - Knox Daily

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Canada

Fortress Biotech: Q2 Earnings Snapshot - Darien Times

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com UK

Fortress Biotech: Q2 Earnings Snapshot - San Antonio Express-News

Fortress Biotech: Q2 Earnings Snapshot - New Haven Register

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

Fortress Biotech: Q2 Earnings Snapshot - San Francisco Chronicle

Fortress Biotech: Q2 Earnings Snapshot - Thehour.com

Fortress Biotech: Q2 Earnings Snapshot - Houston Chronicle

Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - StockTitan

Fortress Biotech Inc Azioni (FBIO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Fortress Biotech Inc Azioni (FBIO) insider trading

Simile a FBIO